Management of Lower-risk MDS without Del5q and Refractory to ESAs

imedex has 1334 videos Subscribe Here

Description: Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.

In this presentation, Dr. Amy E. DeZern discusses the management of cases of lower-risk MDS lacking del5q and refractory to ESAs.

© 2015 Imedex, LLC.
Shared By : imedex
Posted on : 11/13/15
Added : 4 years ago